Covid testing system at risk of ‘collapse’ when travel reopens
Coronavirus tests for people in quarantine are routinely arriving late, warns consumer group
The UK’s coronavirus testing system for holidaymakers could “buckle” this summer as private labs are failing to keep up with demand.
Consumer group Which? has warned that Covid tests for people in quarantine are routinely arriving late, with passengers having to extend their isolation period or pay for additional Covid tests because of the delays.
With passenger numbers just a fraction of their usual levels due to restrictions on overseas travel, Which? says the system may not be able to “cope with demand” when international travel resumes to a limited number of countries on 17 May, says The Telegraph.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Travellers arriving in the UK must currently quarantine for a mandatory ten days and take a PCR test on day two and day eight of that period. These tests typically cost between £160 and £200, but can cost over £500. Test users must receive negative results for both these tests before they can leave quarantine on day ten of their isolation.
But Which? has said social media and review sites are already “flooded” with complaints from people who have suffered delays in receiving their test kits and results.
Holidaymakers could also be fined up to £2,000 if they fail to comply with government rules, reports Metro.
Some providers have pointed to delays with Royal Mail deliveries, but Royal Mail has said there are no delays in its network in relation to the use of priority postboxes for travellers’ test results.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Rory Boland, editor of Which? Travel magazine, said: “The UK’s travel testing system can’t cope with demand, even when relatively small numbers of people are travelling,” the Independent reports.
“It’s clear the system could buckle under the pressure when mass international travel restarts and hundreds of thousands more people are reliant on it. Travellers shouldn’t have to shop around for something as crucial as a test provider. They simply need a service that is accessible, reliable and delivered on time.”
The Department of Health and Social Care told The Telegraph it was “carefully monitoring” any issues raised by the public, and was “raising every complaint” with private test providers.
“We also monitor all providers’ performance, including their delivery and test turnaround times. We will take rapid action against any company that is providing an inadequate service.
“In the first instance, they will receive a warning and are given five days to demonstrate they have addressed concerns, and if not, they are removed from the gov.uk list.”
-
'The disconnect between actual health care and the insurance model is widening'
Instant Opinion Opinion, comment and editorials of the day
By Anya Jaremko-Greenwold, The Week US Published
-
Cautious optimism surrounds plans for the world's first nuclear fusion power plant
Talking Point Some in the industry feel that the plant will face many challenges
By Justin Klawans, The Week US Published
-
Explore new worlds this winter at these 6 enlightening museum exhibitions
The Week Recommends Discover the estrados of Spain and the connection between art and chess in various African countries
By Catherine Garcia, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published